Search the Appendices of Resolution CM/Res(2018)1

Filters

Display National data
2185 found
INN ATC Code ▼ Country Classification Last update MA Number Registration date Status
LEFLUNOMIDE L04AK01 PT POM 14-05-2018 PT/H/1041/002/DC 04-09-2013 VALID
IPTACOPAN L04AJ08 PT POM 22-10-2024 EMEA/H/C/005764 17-05-2024 VALID
CROVALIMAB L04AJ07 PT POM 22-10-2024 EMEA/H/C/006061 22-08-2024 VALID
ZILUCOPLAN L04AJ06 PT POM 22-10-2024 EMEA/H/C/005450 01-12-2023 VALID
AVACOPAN L04AJ05 PT POM 22-10-2024 EMEA/H/C/005523 11-01-2022 VALID
SUTIMLIMAB L04AJ04 PT POM 22-10-2024 EMEA/H/C/005776 15-11-2022 VALID
PEGCETACOPLAN L04AJ03 PT POM 22-10-2024 EMEA/H/C/005553 13-12-2021 VALID
RAVULIZUMAB L04AJ02 PT Not authorised VALID
EVEROLIMUS L04AH02 PT II None VALID
ROZANOLIXIZUMAB L04AG16 PT POM 22-10-2024 EMEA/H/C/005824 05-01-2024 VALID
UBLITUXIMAB L04AG14 PT POM 22-10-2024 EMEA/H/C/005914 31-05-2023 VALID
OFATUMUMAB L04AG12 PT POM 13-10-2021 EMEA/H/C/005410 26-03-2021 VALID
ANIFROLUMAB L04AG11 PT POM VALID
INEBILIZUMAB L04AG10 PT POM 22-10-2024 EMEA/H/C/005818 25-04-2022 VALID
OCRELIZUMAB L04AG08 PT POM VALID
ALEMTUZUMAB L04AG06 PT POM VALID
BELIMUMAB L04AG04 PT POM VALID
NATALIZUMAB L04AG03 PT POM 24-10-2017 VALID
RITLECITINIB L04AF08 PT POM 22-10-2024 EMEA/H/C/006025 15-09-2023 VALID
DEUCRAVACITINIB L04AF07 PT POM 22-10-2024 EMEA/H/C/005755 24-03-2023 VALID
FILGOTINIB L04AF04 PT POM 26-01-2021 EMEA/H/C/005113 24-09-2020 VALID
UPADACITINIB L04AF03 PT POM 05-06-2020 EMEA/H/C/004760 16-12-2019 VALID
BARICITINIB L04AF02 PT POM 22-08-2017 EMEA/H/C/004085 13-02-2017 VALID
TOFACITINIB L04AF01 PT POM VALID
ETRASIMOD L04AE05 PT POM 22-10-2024 EMEA/H/C/006007 16-02-2024 VALID
PONESIMOD L04AE04 PT POM 13-10-2021 EMEA/H/C/005163 19-05-2021 VALID
SIPONIMOD L04AE03 PT POM 05-06-2020 EMEA/H/C/004712 13-01-2020 VALID
OZANIMOD L04AE02 PT POM 05-10-2020 EMEA/H/C/004835 20-05-2020 VALID
FINGOLIMOD L04AE01 PT POM VALID
VOCLOSPORIN L04AD03 PT POM 22-10-2024 EMEA/H/C/005256 15-09-2022 VALID
TACROLIMUS L04AD02 PT POM VALID
CICLOSPORIN L04AD01 PT POM VALID
MIRIKIZUMAB L04AC24 PT POM 22-10-2024 EMEA/H/C/005122 26-05-2023 VALID
SPESOLIMAB L04AC22 PT POM 22-10-2024 EMEA/H/C/005874 09-12-2022 VALID
BIMEKIZUMAB L04AC21 PT POM 13-10-2021 EMEA/H/C/005316 20-08-2021 VALID
SATRALIZUMAB L04AC19 PT POM 13-10-2021 EMEA/H/C/004788 24-06-2021 VALID
RISANKIZUMAB L04AC18 PT POM VALID
TILDRAKIZUMAB L04AC17 PT POM 14-11-2018 EMEA/H/C/004514 17-09-2018 VALID
GUSELKUMAB L04AC16 PT POM 14-11-2018 EMEA/H/C/004271 15-11-2017 VALID
SARILUMAB L04AC14 PT POM 06-11-2017 EMEA/H/C/004254 23-06-2017 VALID
IXEKIZUMAB L04AC13 PT POM 22-08-2017 EMEA/H/C/003943 25-04-2016 VALID
BRODALUMAB L04AC12 PT POM 06-11-2017 EMEA/H/C/003959 17-07-2017 VALID
SECUKINUMAB L04AC10 PT POM VALID
USTEKINUMAB L04AC05 PT I None VALID
ANAKINRA L04AC03 PT POM VALID
BASILIXIMAB L04AC02 PT POM VALID
DACLIZUMAB L04AC01 PT Not authorised 13-11-2018 VALID
GOLIMUMAB L04AB06 PT POM VALID
CERTOLIZUMAB PEGOL L04AB05 PT POM VALID
ADALIMUMAB L04AB04 PT POM VALID